GLP-1s and Muscle Mass: How Worried Should You Be?
Rapid weight loss takes lean tissue along with fat. New research clarifies how much, and what to do about it.
A person curling a dumbbell in a minimal home gym lit by window light.
One of the more durable concerns about GLP-1 therapy is muscle loss. The concern is real. The magnitude has been overstated.
What the data shows
Across the major trials, roughly 25–40% of weight lost on GLP-1 therapy is lean mass. That figure sounds alarming until you compare it to weight loss by other means — caloric restriction alone produces a similar ratio.
Why the ratio matters less than the trajectory
Muscle loss tracks with total weight loss and with age. The patients at highest risk are older adults losing weight quickly without resistance training.
The problem is not the medication. It is losing 20% of your body weight while doing nothing with your muscles.
What the evidence supports
- Two resistance-training sessions per week meaningfully attenuates lean loss
- Protein intake of 1.4–1.6 g/kg per day supports retention
- Slower titration reduces both side effects and lean-mass loss
What is still unknown
Whether the lean tissue lost during GLP-1 therapy is functionally equivalent to lean tissue lost otherwise. Early imaging studies suggest yes. Definitive answers will require longer follow-up.
For now: lift, eat protein, and do not panic.
